Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
York, UK -- Pharmalicensing Ltd today announced the launch of a new features section of pharmalicensing.com, the online resource for pharmaceutical and biotech business development More
The report, by Pharmalicensing founder Steve Poile and Head of Publishing Suzanne Elvidge, is an in-depth review of licensing structures and strategies for discovery and preclinical deals, supported with case studies and deals data analysis. More
AGI Therapeutics plc, announced its admission to trading on AIM and IEX in a €42.5 Million (£29.2 million) Placing on 27 February 2006, which was arranged by Davy. More
Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
Pharmalicensing.com, the leading online technology exchange for life sciences, has announced the launch of its Solutions Directory, an efficient way to locate contract services for all stages of the product development process More
Lombard Medical Technologies PLC, a developer of stent grafts and other medical products, announced on 7th December 2005 that it had successfully completed an initial public offering on the AIM market of the London Stock Exchange More
Intercytex Group plc announced on 1st February 2006 that it had successfully completed an initial public offering on the AIM market of the London Stock Exchange, raising £15 million. More
The report, by Pharmalicensing founder Steve Poile and Head of Publishing Suzanne Elvidge, is an in-depth review of licensing structures and strategies for discovery and preclinical deals, supported with case studies and deals data analysis. More
Displaying 1..10 of 16 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
